يعرض 1 - 10 نتائج من 92 نتيجة بحث عن '"CLINICAL FEATURE"', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: ŞİMŞEK, MELİH

    المصدر: Cancer Investigation. 39:473-481

    مصطلحات موضوعية: Oncology, Turkey, retrospective study, T-DM1, diarrhea, heart failure, thrombocytopenia, 0302 clinical medicine, aspartate aminotransferase, infusion related reaction, estrogen, genetics, Neoplasm Metastasis, cancer survival, skin and connective tissue diseases, Aged, 80 and over, progression free survival, portal hypertension, clinical trial, General Medicine, nausea, anemia, Metastatic breast cancer, 030220 oncology & carcinogenesis, immunological antineoplastic agent, oral mucositis, musculoskeletal diseases, medicine.medical_specialty, progesterone, Article, multiple cycle treatment, paresthesia, hypomagnesemia, 03 medical and health sciences, turkey (bird), neutropenia, metastasis, Humans, human, acne, cystitis, neoplasms, human epidermal growth factor receptor 2 positive breast cancer, Aged, Retrospective Studies, trastuzumab emtansine, hypophosphatemia, leukopenia, ERBB2 protein, human, thromboembolism, hyperkalemia, medicine.disease, major clinical study, Survival Analysis, drug efficacy, multicenter study, 030104 developmental biology, chemistry, epidermal growth factor receptor 2, fatigue, proteinuria, disease activity, drug tolerability, drug hypersensitivity, 0301 basic medicine, vomiting, Cancer Research, drug safety, hyponatremia, Survival, Receptor, ErbB-2, very elderly, efficacy, hyperuricemia, hypocalcemia, Ado-Trastuzumab Emtansine, Turkey (republic), chemistry.chemical_compound, Antineoplastic Agents, Immunological, brain metastasis, pain, lapatinib, hypernatremia, breast tumor, Middle Aged, visceral metastasis, humanities, trastuzumab, Treatment Outcome, gamma glutamyltransferase, immunohistochemistry, Female, real world experience.-, Cancer investigation, ss.1-22, 2021 [Bahçeci A., Paydaş S., Ak N., Ferhatoğlu F., Saip P. M. , Seydaoğlu G., Bilici M., Şimşek M., Tekin S. B. , Çalikuşu Z., et al., -Efficacy and safety of trastuzumab emtansine in Her2 positive metastatic breast cancer], bilirubin, alkaline phosphatase, Receptor, Adult, congenital, hereditary, and neonatal diseases and abnormalities, side effect, alanine aminotransferase, overall survival, Breast Neoplasms, spine metastasis, delirium, male, pertuzumab, acute kidney failure, Internal medicine, hypokalemia, medicine, pneumonia, controlled study, fluorescence in situ hybridization, business.industry, liver failure, hypercalcemia, hypertransaminasemia, toxicity, alopecia, hand foot syndrome, human tissue, real-world experience, clinical feature, febrile neutropenia, hypoglycemia, Trastuzumab emtansine, hyperglycemia, business, metabolism

  3. 3
  4. 4
  5. 5
  6. 6

    المصدر: Bulletin of Russian State Medical University

    وصف الملف: application/pdf

  7. 7

    المساهمون: Bursa Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyoloji ve Genetik Anabilim Dalı., Bursa Uludağ Üniversitesi/Tıp Fakültesi/Genel Cerrahi Anabilim Dalı., Bursa Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı., Bursa Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı., Çeçener, Gülşah, Takanlou, Leila Sabour, Takanlou, Maryam Sabour, Egeli, Ünal, Aksoy, Seçil, Ünal, Ufuk, Tezcan, Havva, Eryılmaz, Işıl Ezgi, Gökgöz, Mustafa Şehsuvar, Tunca, Berrin, Çubukçu, Erdem, Evrensel, Türkkan, Çetintaş, Sibel, Taşdelen, İsmet, GGI-6227-2022, EAS-6830-2022, GYU-0252-2022, EWY-5692-2022, ETP-1691-2022, EOI-5652-2022, EBN-1186-2022

    المصدر: Cancer Genetics. 240:23-32

    مصطلحات موضوعية: Male, Oncology, Kaplan Meier method, Turkey, endocrine system diseases, Epidemiology, DNA Mutational Analysis, Gene mutation, Germline, Heteroduplex analysis, Human epidermal growth factor receptor 2 positive breast cancer, Breast cancer, 0302 clinical medicine, Pathology, Tumor suppressor gene, Disease free survival, skin and connective tissue diseases, 030220 oncology & carcinogenesis, Cohort analysis, Breast carcinoma, Human, medicine.medical_specialty, Ovarian-cancer, Major clinical study, Article, Disease-Free Survival, Cancer grading, 03 medical and health sciences, Genetic screening, Genetics, Pathogenicity, Humans, Women, Vairants, Molecular Biology, Genetic predisposition, Follow up, BRCA1, medicine.disease, BRCA2, Gene frequency, BRCA2 protein, human, Mutation, Sanger sequencing, Cancer Research, Kaplan-Meier Estimate, Associations, Turkey (republic), Turkey (bird), Germline mutation, Pathogenic mutations, Prevalence, Tumor volume, Overall survival, Triple negative breast cancer, Breast, Family history, Priority journal, BRCA1 Protein, Genetics & heredity, Tumor characteristics, Middle Aged, Mutation (genetic algorithm), symbols, Female, Variant of uncertain significance, Genetic trait, Risk, Adult, Heterozygote, BRCA1 Gene, Breast Neoplasms, Germline Mutation, Ovary cancer, Luminal B breast cancer, Breast tumor, Biology, Breast Neoplasms, Male, symbols.namesake, Luminal A breast cancer, Internal medicine, medicine, Genetic Predisposition to Disease, Mortality, Germline mutations, Popoulation, Germ-Line Mutation, BRCA1 protein, human, BRCA2 Protein, Clinical feature, Genetic association, Physical-activity, Genetic variability, Ovarian cancer, Controlled study, Follow-Up Studies

  8. 8
  9. 9
  10. 10